Newsletter
IOL Chemicals received approval from China’s drug regulator to export its Ibuprofen drug.
The deets: IOL Chemicals is one of India’s top makers of active pharmaceutical ingredients (APIs).
Meanwhile, Ibuprofen is a go-to medicine for pain relief, inflammation, and fever. With this approval, the company can now directly sell Ibuprofen in the massive Chinese market.
Why it matters: breaking into China’s tightly regulated pharma market is no small feat. It opens a huge new revenue stream for IOL and reduces its reliance on traditional export markets.
Zoom out: the global Ibuprofen market is worth around $6.5 billion and China alone accounts for roughly 15% of global Ibuprofen consumption.
India’s pharmaceutical exports have been steadily climbing over the last decade—topping $30 billion in FY25.
